The iodine/DMAP-mediated intramoleculartandem C–C/C–O bond forming reaction of malonate bearing alkene moiety proceeded to give bicyclic lactones with good diastereoselectivity in good yield. The mechanistic investigation was also discussed on the basis of various control experimental results.
Pd(II)-Catalyzed [4 + 2] Heterocyclization Sequence for Polyheterocycle Generation
作者:Elizabeth L. Glaisyer、Michael S. Watt、Kevin I. Booker-Milburn
DOI:10.1021/acs.orglett.8b02543
日期:2018.9.21
A new Pd(II)-catalyzed cascade sequence for the formation of polyheterocycles, from simple starting materials, is reported. The sequence is applicable to both indole and pyrrole substrates, and a range of substituents are tolerated. The reaction is thought to proceed by a Pd(II)-catalyzed C–H activated Heck reaction followed by a second Pd(II)-catalyzed aza-Wacker reaction with two Cu(II)-mediated
Synthesis of 2-acyl-3-chloropyrroles: Application to the synthesis of the trail pheromone of the ant Atta texana
作者:Kourosch Abbaspour Tehrani、Didier Borremans、Norbert De Kimpe
DOI:10.1016/s0040-4020(99)00106-4
日期:1999.3
alkoxides in the corresponding alcohol and final acid hydrolysis of the resulting orthoester or acetal functions into the 3-chloropyrrole. The developed strategy is applied to the synthesis of the trailpheromone of the ant Atta texana.
Sjoeholm, Asa; Hemmerling, Martin; Pradeille, Nicolas, Journal of the Chemical Society. Perkin Transactions 1 (2001), 2001, # 8, p. 891 - 899
作者:Sjoeholm, Asa、Hemmerling, Martin、Pradeille, Nicolas、Somfai, Peter
DOI:——
日期:——
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
申请人:AMGEN INC.
公开号:US20210230189A1
公开(公告)日:2021-07-29
Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I,
and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.